AAIC 2025 Abstract
Interlaboratory comparison of amyloid‐beta [AB1‐42], [AB1‐40] and its ratio derived from CSF at two reference laboratories using the lumipulse platform
Study in peopleBiomarkers
Abstract
Background: The high accuracy and precision of cerebral spinal fluid (CSF) biomarkers for the assessment of Alzheimer's Disease (AD) pathology has allowed regulatory approval and global clinical acceptance of these tools.
